The new SQUID biosusceptometer at Oakland: first year of experience
- PMID: 16012600
The new SQUID biosusceptometer at Oakland: first year of experience
Abstract
Liver iron measurements using biosusceptometers have been validated on two low-TC SQUID (Superconducting Quantum Interference Device) systems (New York and Hamburg) built in the 1980's. Recently, two new instruments have been installed in Torino, Italy (2001), and Oakland, California (2003). The design of the Oakland system is similar to those in Hamburg and Torino. Improvements were made to adjust for significant environmental noise, moreover, an active electronic noise cancellation, a computer controlled water coupling reference system using a pressure feedback and a faster data acquisition system using software lockin amplifiers have been implemented. All 3 systems (Hamburg, Torino, Oakland) are using the same standardized operational protocol. Presented herein are the data collected from 276 patients measured with the SQUID biosusceptometer at Oakland since installation. The results from 149 patients with beta-thalassemia (beta-Thal, age: 2-66 y), 76 patients with sickle-cell disease (SCD, age: 5-55 y), 35 patients with various rare diseases (RD, age: 2-80 y), and 16 patients with hereditary hemochromatosis (HHC, age: 6-74 y) are reported. The liver iron concentration in the different groups are 222 - 7570 (beta-Thal), 518 - 7918 (SCD), 511 - 6234 (RD), 258 - 2041 (HHC) microg/g-liver (in vivo wet weight). The long-term reproducibility (12 months) in a patient on constant treatment regimen demonstrated a mean liver iron of 1141 +/- 133 microg/g-liver. The new SQUID Ferritometer located on the US West coast will give more patients access to this non-invasive liver iron assessment.
Similar articles
-
Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.Pediatr Blood Cancer. 2007 Sep;49(3):329-32. doi: 10.1002/pbc.21275. Pediatr Blood Cancer. 2007. PMID: 17554789
-
Total iron-overload measurement in the human liver region by the magnetic iron detector.IEEE Trans Biomed Eng. 2010 Sep;57(9):2295-303. doi: 10.1109/TBME.2010.2053204. Epub 2010 Jun 17. IEEE Trans Biomed Eng. 2010. PMID: 20562030
-
Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.Am J Hematol. 2007 Apr;82(4):255-65. doi: 10.1002/ajh.20809. Am J Hematol. 2007. PMID: 17094096
-
In vivo tissue characterization using magnetic techniques.Neurol Clin Neurophysiol. 2004 Nov 30;2004:85. Neurol Clin Neurophysiol. 2004. PMID: 16012653
-
Beta-thalassemia: the Lebanese experience.Clin Lab Haematol. 2006 Aug;28(4):217-27. doi: 10.1111/j.1365-2257.2006.00792.x. Clin Lab Haematol. 2006. PMID: 16898958 Review.
Cited by
-
Validation of liver quantitative susceptibility mapping across imaging parameters at 1.5 T and 3.0 T using SQUID susceptometry as reference.Magn Reson Med. 2023 Apr;89(4):1418-1428. doi: 10.1002/mrm.29529. Epub 2022 Nov 21. Magn Reson Med. 2023. PMID: 36408802 Free PMC article.
-
Diabetes in HFE Hemochromatosis.J Diabetes Res. 2017;2017:9826930. doi: 10.1155/2017/9826930. Epub 2017 Feb 26. J Diabetes Res. 2017. PMID: 28331855 Free PMC article. Review.
-
Dual-energy X-ray absorptiometry with serum ferritin predicts liver iron concentration and changes in concentration better than ferritin alone.J Clin Densitom. 2010 Oct-Dec;13(4):399-406. doi: 10.1016/j.jocd.2010.05.003. Epub 2010 Jul 21. J Clin Densitom. 2010. PMID: 20663700 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Miscellaneous